Videra Surgical Inc. news

Study Demonstrate Superiority of VeraForm® Marker Over Clips

For Tumor Bed Delineation Accuracy

San Francisco CA, October 28, 2021- Videra Surgical Inc., the developer of the novel adaptable tumor bed marker VeraForm® for breast cancer surgery, announced the presentation of

Head and neck cancer surgery presents a number of unique challenges, not only for the surgeon but for the radiation oncologist who will subsequently treat those patients. Great care with an emphasis on precision must be taken to ensure that critical structures and tissues avoid collateral damage when possible. However, given the surgical site often lies in soft tissue, exact identification of the native tumor bed can present some difficulty for radiation planning.

Radiation therapy choices vary for comprehensive breast cancer treatment. One such option, intraoperative radiation therapy (IORT) is employed in many centers around the country. IORT using the Zeiss® Intrabeam® System has been proven to be non-inferior to External Beam Radiation Therapy (EBRT) in local recurrence and disease-free survival. IORT’s advantage is one treatment during surgery instead of several weeks of EBRT which has obvious benefits for patient convenience,

VeraForm® placement to assist with localization and delivery of adjuvant radiation

Historically, lumpectomies resulted in a scar immediately over the lumpectomy site, dictating delivery of adjuvant radiation on scar location, and frequently on the presence of a seroma. Currently, the question persists as to the optimal means to help direct the radiation oncologist to effectively deliver radiation in the oncoplastic era.  With oncoplastic surgery, the lumpectomy site

As a patient facing breast cancer surgery, you should know that precise "marking" of your cancer surgical site is an important part of your treatment. A marker is a device inserted at the surgical site. Precision in marking helps make sure you retain as much normal breast tissue as possible with the surgery. This ultimately leads to best overall post-surgical care by your wellness team. A new technology called VeraForm, developed by Videra Surgical Inc. and a group of cancer specialists

Our Medical Director of the Oncology Breast Program, Dr. Beth DuPree, was first in the U.S. to adopt VeraForm, a continuous, radiopaque 3D tissue marker. Within months, its utility led to quick integration into our program’s standard daily practice. Like all centers today, patient satisfaction is a focal point and to date, we have seen no complications or toxicities by any criteria (e.g., CTCAE) while employing VeraForm. Further, we have received no complaints by patients such as

Tomosynthesis imaging is a critical technology in the treatment of breast cancer and 3-D intraoperative specimen imaging is state-of-the art. The MOZART® System from KUBTEC Medical Imaging stands alone as it identifies the exact location of three dimensional objects such as tumors and localization devices inside breast cancer specimens. The VeraForm adaptable tissue marker is

It’s always been distressing to explain to surgeons that their meticulously placed lumpectomy clips are much less useful to radiation oncologists than they originally perceived. Maybe it’s because of the desperate appreciation that radiation oncologists express when even one clip is left behind. In this current era of de-escalating therapies, patients receiving breast radiation therapy, especially a boost, are known to have the very highest risk of local failure. In other wo